Subscribe

Explaining Treatment Regimens to Patients with HR+/HER2- Metastatic Breast Cancer

Breast Cancer, Video
Videos
Dr Thomas Bachelot is careful to set reasonable expectations for his patients with HR+/HER2- metastatic breast cancer regarding how long their treatment will last and how it will impact them.

Related Items

Adjuvant T-DM1 Improves Survival vs Trastuzumab in Early High-Risk HER2-Positive Breast Cancer
By Phoebe Starr
TON - February 2024 Vol 17, No 1
Breast Cancer, SABCS
Supervised Exercise Program Enhances Quality of Life and Fitness in Patients With Metastatic Breast Cancer
By Wayne Kuznar
TON - February 2024 Vol 17, No 1
SABCS, Breast Cancer
Ribociclib Plus Endocrine Therapy Improves Invasive Disease-Free Survival in Patients With HR-Positive, HER2-Negative, Early Breast Cancer
By Patricia Stewart
Web Exclusives
ASCO 2023 Highlights, Breast Cancer
Pausing Endocrine Therapy to Become Pregnant Appears Safe for Women with Breast Cancer
By Patricia Stewart
TON - April 2023 Vol 16, No 2
Breast Cancer, SABCS 2023
Ribociclib plus Endocrine Treatment Outperforms Chemotherapy in Advanced Breast Cancer
By William King
TON - February 2023 Vol 16, No 1
Breast Cancer, SABCS
CTC Count May Help Providers Choose Optimal Therapy for Patients with Metastatic Breast Cancer
By William King
TON - February 2023 Vol 16, No 1
SABCS, Breast Cancer
Addition of Capivasertib to Fulvestrant Improves Outcomes in Metastatic Breast Cancer
By William King
TON - February 2023 Vol 16, No 1
SABCS, Breast Cancer
Radiation Therapy May Be Safely Omitted for Some Older Patients with Luminal A Breast Cancer
By Patricia Stewart
TON - October 2022 Vol 15, No 5
Breast Cancer
Key Factors Associated with Early Discontinuation of Abemaciclib in Patients with Breast Cancer in the MonarchE Trial
By William King
TON - October 2022 Vol 15, No 5
Breast Cancer
Trastuzumab Deruxtecan Is a New Standard of Care for Patients with HER2-Low Metastatic Breast Cancer
By William King
TON - August 2022 Vol 15, No 4
Breast Cancer

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.